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Erythropoietin gene regulation depends on heme-dependent oxygen
sensing and assembly of interacting transcription factors. Studies on
eiythropoietin (Epo) gene expression have been useful in investigating the
mechanism by which cells and tissues sense hypoxia. Both in vivo and in
Hep3B cells, Epo production is induced not only by hypoxia but also by
certain transition metals (cobalt and nickel) and by iron chelation. When
Hep3B cells were incubated in an iron deficient medium, Epo mRNA
expression was enhanced fourfold compared to Hep3B cells in iron
enriched medium. Epo induction by cobalt was inversely related to iron
concentration in the medium, indicating competition between the two
metals. Under hyperbaric oxygen, cobalt induction of erythropoietin
mRNA was modestly suppressed while nickel induction was markedly
enhanced. These recent observations support the proposal that the oxygen
sensor is a heme protein in which cobalt and nickel can substitute for iron
in the porphyrin ring. The up-regulation of Epo gene transcription by
hypoxia depends on at least two known DNA binding transcription factors,
HIF-1 and HNF-4, which bind to cognate response elements in a critical
—50 bp 3' enhancer. Hypoxia induces HIF-1 binding. HNF-4, an orphan
nuclear receptor constitutively expressed in kidney and liver, binds
downstream of HIF-1 and cooperates with HIF-1, contributing impor-
tantly to high level and perhaps tissue specific expression. The C-terminal
activation domain of HNF-4 binds to the f3 subunit of HIF-l. The
C-terminal portion of the a subunit of HIF-I binds specifically to p300, a
general transcriptional activator. Hypoxic induction of the endogenous
Epo gene in Hep3B cells as well as an Epo-reporter gene was fully
inhibited by E1A, an adenovirus protein that binds to and inactivates p300,
but only slightly by a mutant E1A that fails to bind to p300. Moreover,
overexpression of p300 enhanced hypoxic induction. Thus, it is likely that
in hypoxic cells, p300 or a related family member plays a critical role in
forming a macromnlecular assembly with HIF-1 and HNF-4, enabling
transduction from the Epo 3' enhancer to the apparatus on the promoter
responsible for the initiation of transcription.
Organismal, tissue and cellular responses to hypoxia depend in
large part on alterations in the expression of genes controlling a
diverse array of physiologically relevant processes. In order to
understand this critically important mode of molecular adapta-
tion, we need to learn more about the mechanisms by which
oxygen is sensed, the transduction of the hypoxic signal and the
resulting impact of this signaling process on the assembly of
transcription factors that regulate these genes. There is growing
evidence that most if not all tissues and cells share a common
mechanism for oxygen sensing and signal transduction [1]. As
shown in Table 1, a number of genes are induced not only by
hypoxia, the physiologic stimulus, but also by certain transition
metals (cobalt, nickel and manganese) and by iron chelators such
as desferrioxamine. Moreover, the hypoxic induction is markedly
attenuated in the presence of carbon monoxide. We have pre-
sented evidence that the sensing mechanism utilizes a heme
protein that binds oxygen and in which the iron atom of the heme
can be replaced by cobalt, thereby mimicking the hypoxic state [21.
Acker and his colleagues [3—6] have obtained spectral and
immunologic evidence that the sensor is a eytoehrome b like flavo
heme protein and that the signal transduction process involves
alterations in the levels of reactive oxygen intermediates [7, 8].
The genes listed in Table 1, as well as others, also share a common
mode of transcriptional regulation. Their hypoxic induction de-
pends upon activation of a heterodimeric transcription factor HIF-1
which binds to a consensus sequence in an enhancer or promoter.
We have studied the regulation of the erythropoietin gene as a
paradigm of hypoxic induction of physiologically relevant genes.
Erythropoietin (Epo) is a 30.4 kDa glycoprotein hormone, pro-
duced in the kidney and liver in response to hypoxia. It circulates
in the plasma and binds to receptors specifically expressed on
erythroid progenitor and precursor cells, enabling them to prolif-
erate and differentiate into red blood cells. Epo is an ideal model
system to study hypoxic regulation: (a) it has obvious biologic
importance; (b) its expression is up-regulated 50 to 100 fold by
physiologically relevant levels of hypoxia; (c) the Epo gene offers
an opportunity to investigate the basis for tissue specific and
development specific expression; (d) investigation of the regula-
tion of the Epo gene has been greatly facilitated by the use of two
human hepatoma cell lines, which have been shown to produce
Epo in a physiologically regulated manner: up-regulation in
response to hypoxia [9].
In this review, we present recent work from our lab and that of
collaborators that provides new information on the mechanism by
which oxygen is sensed in Hep3B cells, as well as on the assembly
of transcription factors that contribute importantly to hypoxic and
tissue-specific induction of the transcription apparatus.
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Oxygen sensing
Any model based on oxygen sensing via a heme protein predicts
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%02
Co (tM) 0 0 2 4* 10 25 25 0
Fe (tM) 0.4 4.4 0.4 0.4 0.4 0.4 4.4 0.4
1 2 3 4 5 6 7 8
Table 1. Properties of oxygen regulated genes
Epo TH VEGF PGKI GLUT-i PCK
mRNA expression
Hypoxia I I I I I I
Hypoxia + CO I I I
CoCl2 ' ¶ '' I I I
Desferroxamine I I I I
cyclohexamide blocks Y Y Y Y
induction
Functional HIF-1 binding 'Y Y Y Y Y
mRNA stability in hypoxia ? 1' ' I
Abbreviations are: Epo, eiythropoietin; TH, tyrosine hydroxylase;
VEGF, vascular endothelial-derived growth factor; PGKI, phosphoglyc-
erokinase I; GLUT-i, glucose transporter 1; PCK, phosphoenolpyruvate
carboxykinasc.
This table adapted from [1]. Symbols arc: , induction; , suppression;
Y, yes.
such as Epo. If the effect of cobalt and nickel depends on
incorporation into the heme moiety, increased levels of iron
should competitively inhibit the stimulatory effects of these metals
on Epo gene. Furthermore, since iron catalyzes the conversion of
peroxide to reactive oxygen intermediates via the Fenton reaction,
it may significantly alter levels of chemical messengers in the
oxygen sensing pathway. This is a plausible explanation of the
observation of Wang and Semenza [10] that the iron chelating
Fig. 1. Ribonuclease protection analysis
demonstrating the effect of iron on Epo mRNA
expression in the absence and presence of cobalt
induction. Hep3B cells were incubated in low
iron medium (total iron = 0.43 jLM) and under
21% 02 (except in lane 8 where cells were
exposed to 1% 02). In lanes 2 and 7, iron was
added as the iron transferrin complex (Fe2-Tf).
In lanes 3 to 6, cobalt was added, either as
CoCl2 (lanes 3, 5 and 6) or as the cobalt
transferrin complex (Co2-Tf) (lane 4). Adapted
from Ho and Bunn [ii].
agent, desferrioxamine, activates HIF-1 DNA binding activity and
Epo mRNA expression. We have investigated the effect of iron
concentration on Epo gene expression and the impact of iron on
stimulation of Epo mRNA by cobalt p11].
As shown in Figure 1, Hep3B cells incubated for 48 hours at
21% 02 in low iron medium (total iron concentration = 2.5
jxg!dl 0.43 /kM) (lane I) expressed a moderate amount of Epo
mRNA. When iron-transferrin complex (Fe2-TF) was added to
this low iron medium to give a final concentration of 4.4 /.tM Fe3,
expression was markedly inhibited (lane 2). Addition of increasing
amounts of CoCI2 in low iron medium (lanes 3 to 6) resulted in a
marked and progressive induction of Epo mRNA. Addition of
cobalt-transferrin complex (Co2-TF) (final concentration of 4 LM
Co34), shown in lane 4, resulted in an induction of Epo mRNA
comparable to that obtained with 10 tM CoCI2 (lane 5). When the
medium was supplemented with Fe2-TF [4.4 xM Fe3], the cobalt
response was abolished (lane 7). These results suggest that
transferrin enables efficient uptake of cobalt into Hep3B cells and
that iron competes directly with cobalt and interferes with cobalt's
ability to induce the Epo gene, probably at the level of the heme
protein oxygen sensor.
To further investigate the proposal that the oxygen sensor is a
metal-containing heme protein, we investigated the effect of
hyperbaric oxygen on induction of Epo mRNA by cobalt and
nickel. Cobalt protoporphyrin binds oxygen with low affinity
whereas nickel protoporphyrin cannot hind oxygen even at high
21
—Epo
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P02 Therefore, we predicted that, in comparison to nickel
induction, cobalt induction of Epo mRNA would be attenuated
under hyperbaric oxygen. Figure 2 shows the effect of high oxygen
pressure on the expression of Epo mRNA in Hep3B cells after
eight hours incubation with cobalt or nickel. As expected, when
neither metal was present, there was no induction in either I
Atmosphere of 21% 02 (P02 = 140 torr) or in 3 Atm of 98% °2
(P°2 = 2250 torr). At a P°2 of 140 torr, cobalt gave the expected
robust induction. When the cells were subjected to hyperbaric 02,
cobalt induction was slightly diminished. In contrast, at 140 torr
the induction of Epo mRNA by 300 JIM NiCI2 was less than that
by 100 JIM CoCI2 but was markedly enhanced at hyperbaric
oxygen. Consistent with our in vitro results with cobalt, Nccas and
Neuwirt [121 previously demonstrated that when rats were treated
with cobalt and then subjected to 3 atmospheres of 02 in a
hyperbaric chamber, induction of serum Epo levels was suppressed.
The oxygen sensor has been proposed to be a NAD(P)H
oxidase, which, under normoxic conditions, binds free 02 and
converts it to H202 [3—61 (Fig. 3). Hydrogen peroxide is subse-
quently converted to hydroxyl radicals (01-f) and hydroxide
(OH—) through the iron-dependent Fenton reaction. These reac-
tive oxygen intermediates could then act as chemical messengers
that suppress expression of genes induced by hypoxia [7]. A
deficiency of iron may lower production of these reactive oxygen
intermediates, thereby mimicking a hypoxic environment. In the
model depicted in Figure 3, cobalt leads to the induction of HIF-l
and hypoxia responsive genes through its incorporation into the
porphyrin ring of the heme oxygen sensor. Since cobalt heme
binds 02 with extremely low affinity, the oxygen sensor containing
cobalt would generate decreased levels of reactive oxygen inter-
mediates [81, mimicking a hypoxic environment and activating
HIF-1.
The experiments described above may help to explain some
puzzling clinical and experimental observations. The administra-
tion of iron to iron deficient patients can acutely lower the level of
plasma Epo [13, 14], an in vivo effect akin to results shown in
Figure 1, lanes 1 and 2. Patients with sickle cell anemia [151 and
beta thalassemia major and intermedia [161 have significantly
lower levels of plasma erythropoietin than other patients with
—Epo comparable degrees of anemia. In these two hemoglobin disor-
ders, there is a marked increase in hemoglobin catabolism and the
likelihood that heme degradation could significantly raise intra-
cellular iron levels in Epo producing cells, thereby blunting
hypoxic induction. Incorporation of intracellular iron via heme
catabolism might also explain both the inhibition of plasma Epo
production in animals made polycythemic by hypertransfusion
[17—191 and the more marked inhibition in animals treated with
hemin, hemolysate or damaged red cells [20]. Moreover, our
demonstration of the ability of iron to inhibit cobalt induction of
Epo expression (Fig. 1, lanes 6 and 7 and [11]) provides a
plausible explanation of the interesting observation that cobalt
treatment results in a much less marked increase in plasma Epo
levels in mice rendered polycythemic by hypertransfusion, com-
pared to those whose polycythemia was induced by hypobaric
hypoxia [21].
Assembly of transcription factors on the Epo enhancer
Hypoxic induction of the genes listed in Table I as well as a
number of other genes depends in large part on a heterodimeric
transcription factor, hypoxia-inducible factor 1 (HIF-l), which
becomes activated in cells exposed to hypoxia, cobalt or iron
chelators, enabling binding to a consensus sequence (5'-TACGT-
GCT-3') first identified in the Epo 3' enhancer [221. H IF-i activity
can be induced by hypoxia in a variety of non-erythropoietin
producing cells, as demonstrated by its binding specifically to a
HIF-1 consensus oligonucleotide [231 and transactivating a re-
porter gene containing HIF-1 sequence(s) [24]. HIF-l activation,
irrespective of stimulus, depends on de novo protein synthesis [25]
and is inhibited by pretreatment with 2-aminopurine, a protein
kinase inhibitor [261. Treatment of hypoxic cell extracts with
alkaline phosphatase [26] abolishes DNA-binding, suggesting that
phosphorylation may be required for binding.
HIF-1 is composed of 120 kDa a and 91 to 94 kDa 13 subunits
[27]. Recent cloning of HIF-la and p genes [28] showed that
HIF-J is a heteiodimcr composed of basic helix-loop-helix pro-
teins in the PAS family of transcription factors. HIF-la is a novel
protein whereas H/F-i 13 is the previously cloned and character-
ized aryl hydrocarbon receptor nuclear translocator (ARNT) [29].
100 (lIM) 300 (l.tM)
CoOl2 N1CI2
I I I I
ATM 1 3 1 3 1 3
Fig. 2. Cobalt and nickel induction of Epa mRNA in normoxic and
hyperoxic incubation. l-Iep3B cells were treated with 100 JIM CoCl2 or 300
JIM NiCl2 and incubated for eight hours in I Atm (760 mm Hg, 21% 02)
or 3 Atm (2280 mm Hg, 98.3% 02). Two left-hand lanes, Hep3B cells not
treated with metals. From Ho and Bunn [11].
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Downstream of the HIF-1 binding site, the Epo 3' enhancer
contains two tandem consensus steroid hormone response ele-
ments separated by 2 bp (Fig. 4). Mutations at these hexanucle-
otides either abolish or markedly inhibit hypoxic induction of
reporter genes [25, 30—321. Nuclear proteins from a variety of
cells, both normoxic and hypoxic, bind strongly to these tandem
repeats [25, 30]. A variety of hormones whose biological actions
depend upon binding to nuclear receptors [thyroxine, all-trans
retinoic acid (two doses), vitamin D5, [3-estradiol, progesterone,
testosterone and dexamethasone] had no effect on the hypoxic
induction of a reporter gene containing the Epo promoter and
Epo enhancer [30]. These negative results suggested that these
response elements bound to an orphan nuclear receptor, that is, a
DNA binding protein that shares structural homology with hor-
mone binding nuclear receptors but lacks a known ligand. In
screening a variety of in vitro transcribed and translated orphan
receptors [321, HNF-4 was of particular interest since its expres-
sion is limited to renal cortex and liver, sites of Epo production,
and also intestine. The binding of HNF-4 to the Epo enhancer in
Fig. 3. Mode/for hypoxia sensing and signaling
pathway. Cobalt protoporphyrin binds 0, with
very low affinity whereas nickel protoporphyrin
does not bind °2• Abbreviations are: ROl,
reactive oxygen intermediates; HIFa, activated
hypoxia inducible factor; 1-lIFi, inactivated
hypoxia inducible factor. From Ho and Bunn
[11].
Fig. 4. Model of assembly of transcription factors
on the Epo 3' enhancer. The Epo gene is shown
with its 5 exons, depicted as rectangles and the
coding regions shown in black. In hypoxic cells,
the HIF-1 a/3 heterodimer is activated and
binds to a consensus sequence on the 3'
enhancer. Downstream of this sitc, the nuclear
receptor HNF-4 hinds constitutively to tandem
repeat hormone response elements (HRE).
HNF-4 also binds to the /3 subunit of HJF-l.
Both the a and /3 subunits of HIF-1 bind to the
transcriptional activator p300, providing a
mechanism for triggering the Epo promoter to
transcribe Epo mRNA.
Hep3B nuclear extracts was documented by the addition of an
antibody to HNF-4 which supershifted one of the prominent
bands in mobility shift assays. The functional importance of
HNF-4 was demonstrated by both transient and stable transfec-
tion experiments, both overexpression of wild-type HNF-4 and
use of a dominant negative mutant, which bound to DNA but
lacked the C-terminal activation domain [32]. These studies
suggest that the binding of HNF-4 to the Epo enhancer contrib-
utes importantly to both the high level induction of the Epo gene
as well as tissue specificity. It will be important to ascertain
whether HNF-4 has a natural ligand, and, if so, whether the ligand
is modulated by oxidation-reduction chemistry.
Recently, Arany and colleagues [33] demonstrated that the
C-terminal portion of HIF-la binds specifically to p300, a general
transcriptional activator that participates in a number of biologi-
cal functions such as induction of various tissue-specific enhanc-
ers, regulation of cell cycle and stimulation of differentiation
pathways. This very large protein, which is closely homologous to
CREB binding protein (CBP), does not bind to DNA but does
02 + Co




552 1-bang et a!: Hypoxia and the Epo gene
interact with a number of other proteins including cell cycle
pocket proteins and the adenovirus protein E1A. Hypoxic induc-
tion of endogenous Epo and VEGF mRNA as well as an
Epo-reporter gene was inhibited by E1A but not by a mutant E1A
that failed to bind to p300. Moreover, overexpression of p300
enhanced hypoxic induction. Recently, we have utilized the yeast
two-hybrid interaction trap to demonstrate specific binding be-
tween HNF-4 and HIF-1[3 and also between HIF-113 and p1300 (D.
Krainc, L.E. Huang, H.F. Bunn, unpublished results). No binding
of HNF-4 to p300 was observed. Thus, as depicted in Figure 4, it
is likely that the HIF-1 heterodimer, activated by hypoxia, partic-
ipates in a macromolecular assembly with p300 (or a related
family member) and with HNF-4 to transduce a signal to the Epo
promoter, enabling high level transcription. It is very likely that
such a combinatorial process applies to other genes that are
induced by hypoxia. For example, the hypoxic induction of the
LDH-A gene depends on both its HIF-1 site in the promoter and
a nearby CREB bindng site [341, with a likely potential for
activating transcription through CBP or p300.
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